Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 207 institutions that hold shares in the stock, with a total of 60 Million shares, which have been reported (via 13F filing form) to have a value of $2.06 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Farallon Capital Management LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
5,590,602
shares
|
$192 Million
0.76% of portfolio
|
Q1 2024
Added 34.14%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
5,572,021
shares
|
$191 Million
0.0% of portfolio
|
Q1 2024
Added 0.81%
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
4,658,095
shares
|
$160 Million
0.0% of portfolio
|
Q1 2024
Reduced 6.13%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 15, 2024 Q1 2024 |
4,006,000
shares
|
$138 Million
1.84% of portfolio
|
Q1 2024
Reduced 0.12%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
3,138,197
shares
|
$108 Million
0.0% of portfolio
|
Q1 2024
Added 19.52%
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2024 Q1 2024 |
2,964,000
shares
|
$102 Million
1.18% of portfolio
|
Q1 2024
Reduced 15.89%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 10, 2024 Q1 2024 |
2,578,558
shares
|
$88.5 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.7%
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
2,472,690
shares
|
$84.9 Million
0.01% of portfolio
|
Q1 2024
Reduced 2.76%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,012,993
shares
|
$69.1 Million
0.01% of portfolio
|
Q1 2024
Added 23.91%
|
|
Macquarie Group LTD
Australia, C3 |
May 14, 2024 Q1 2024 |
1,959,657
shares
|
$67.3 Million
0.07% of portfolio
|
Q1 2024
Reduced 2.77%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,764,505
shares
|
$60.6 Million
1.35% of portfolio
|
Q1 2024
Reduced 18.01%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2024 Q1 2024 |
1,519,163
shares
|
$52.2 Million
0.55% of portfolio
|
Q1 2024
Reduced 2.23%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
1,282,915
shares
|
$44.1 Million
0.0% of portfolio
|
Q1 2024
Added 2.28%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,180,326
shares
|
$40.5 Million
0.0% of portfolio
|
Q1 2024
Added 139.13%
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 08, 2024 Q1 2024 |
1,108,613
shares
|
$38.1 Million
0.09% of portfolio
|
Q1 2024
Added 5.94%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 14, 2024 Q1 2024 |
1,005,626
shares
|
$34.5 Million
0.03% of portfolio
|
Q1 2024
Added 4.94%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
1,002,461
shares
|
$34.4 Million
0.01% of portfolio
|
Q1 2024
Reduced 6.73%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
928,596
shares
|
$31.9 Million
0.02% of portfolio
|
Q1 2024
Reduced 0.14%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
882,402
shares
|
$30.3 Million
0.03% of portfolio
|
Q2 2023
Added 26.77%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
May 09, 2024 Q1 2024 |
707,342
shares
|
$24.3 Million
0.01% of portfolio
|
Q1 2024
Reduced 0.59%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 15, 2024 Q1 2024 |
667,297
shares
|
$22.9 Million
0.01% of portfolio
|
Q1 2024
Added 14.79%
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 08, 2024 Q1 2024 |
649,385
shares
|
$22.3 Million
0.17% of portfolio
|
Q1 2024
New holding
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
590,493
shares
|
$20.3 Million
0.0% of portfolio
|
Q1 2024
Reduced 4.8%
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
539,582
shares
|
$18.5 Million
0.0% of portfolio
|
Q1 2024
Reduced 11.24%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2024 Q1 2024 |
523,166
shares
|
$18 Million
0.8% of portfolio
|
Q4 2023
Added 79.17%
|